SCHEMBL4874700

SCHEMBL4874700

COC(=O)c1c[c]cc(C)c1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.41
POLB P06746 4/20 0.41
HPGD P15428 2/20 0.39
CYP3A4 P08684 1/20 0.39
ALDH1A1 P00352 3/20 0.38
HSD17B10 Q99714 2/20 0.38
USP2 O75604 1/20 0.38
NR4A2 P43354 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
GAA P10253 3/20 0.36
PKM P14618 1/20 0.36
LMNA P02545 2/20 0.36
TSHR P16473 1/20 0.36
CFTR P13569 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11456734 0.81 KDM4E (0.49) KDM4EPOLBHPGDALDH1A1HSD17B10
SCHEMBL4879013 0.80 GAA (0.42) KDM4EPOLBHPGDALDH1A1HSD17B10
SCHEMBL6202400 0.79 LMNA (0.41) KDM4EPOLBHPGDCYP3A4ALDH1A1
SCHEMBL29760 0.75 ACHE (0.36) KDM4EALDH1A1TDP1
SCHEMBL127749 0.74 CA1 (0.45) KDM4EPOLBHPGDCYP3A4ALDH1A1
SCHEMBL699415 0.73 LMNA (0.52) KDM4EPOLBHPGDALDH1A1HSD17B10
SCHEMBL2551744 0.73 TSHR (0.42) KDM4EPOLBHPGDALDH1A1HSD17B10
SCHEMBL3599330 0.73 KDM4E (0.58) KDM4EPOLBHPGDALDH1A1HSD17B10
SCHEMBL4288278 0.72 TSHR (0.41) KDM4EPOLBHPGDALDH1A1HSD17B10
SCHEMBL12345885 0.72 KDM4E (0.46) KDM4EPOLBHPGDCYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080300288-A1 Alkenyldiarylmethanes, Fused Analogs And Syntheses Thereof PURDUE RESEARCH FOUNDATION (US) 2008-12-04 US disclosed
WO-2007005531-A2 ALKENYLDIARYLMETHANES, FUSED ANALOGS AND SYNTHESES THEREOF PURDUE RESEARCH FOUNDATION (US) 2007-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080300288-A1 Alkenyldiarylmethanes, Fused Analogs And Syntheses Thereof POLRMT, PNP, TYMS KDM4E 1291/4885POLB 62/4885HPGD 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.